Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neuromolecular Med ; 21(3): 250-261, 2019 09.
Article in English | MEDLINE | ID: mdl-31037465

ABSTRACT

Depression is one of the most prevalent and crucial public health problem connected to significant mortality and co-morbidity. Recently, numerous studies suggested that dietary flavanones exhibit neuroprotective and antidepressant effects against various psycho-physiological conditions including depression. The present study is focused on the antidepressant and neuroprotective effects of naringenin (NAR) and the involvement of sonic hedgehog (Shh) signaling in the chronic unpredictable mild stress (CUMS)-induced depression. Twenty-four male Wistar rats were randomly assigned into four groups: CON group (saline s.c.), NAR group (NAR 50 mg/kg, p.o.), CUMS group (subjected to CUMS along with saline p.o.), and CUMS + NAR group (NAR 50 mg/kg p.o. along with CUMS) for 28 days including 1-week pre-treatment with NAR. The results showed that NAR was found to inhibit behavioral abnormalities including increased despair in force swim test, and reduced locomotor activity caused by CUMS in open field test. Moreover, Morris water maze revealed that NAR also mitigates CUMS-associated cognitive impairment. In addition to the antidepressant-like effect, NAR mitigates morphological anomalies in the hippocampal CA1 region and cortex. Furthermore, we observed brain-derived neurotrophic factor (BDNF), Shh, GLI1, NKX2.2, and PAX6 were downregulated in the hippocampus of CUMS-exposed rats, which can be upregulated by NAR pre-treatment. GLI1 is main downstream signaling component of Shh signaling cascade, which further regulates the expression of homeodomain transcription factors PAX6 and NKX2.2.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/drug therapy , Flavanones/therapeutic use , Hedgehog Proteins/physiology , Learning Disabilities/drug therapy , Memory Disorders/drug therapy , Neuroprotective Agents/therapeutic use , Signal Transduction/drug effects , Stress, Psychological/drug therapy , Zinc Finger Protein GLI1/physiology , Animals , Antidepressive Agents/pharmacology , Chronic Disease , Depression/etiology , Depression/metabolism , Depression/prevention & control , Disease Models, Animal , Drug Evaluation, Preclinical , Exploratory Behavior/drug effects , Flavanones/pharmacology , Gene Expression Regulation/drug effects , Hippocampus/chemistry , Hippocampus/drug effects , Homeobox Protein Nkx-2.2 , Learning Disabilities/etiology , Learning Disabilities/metabolism , Learning Disabilities/prevention & control , Male , Maze Learning/drug effects , Memory Disorders/etiology , Memory Disorders/metabolism , Memory Disorders/prevention & control , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neuroprotective Agents/pharmacology , Random Allocation , Rats , Rats, Wistar , Stress, Psychological/physiopathology , Swimming
2.
Neurotoxicology ; 73: 246-257, 2019 07.
Article in English | MEDLINE | ID: mdl-31029786

ABSTRACT

Alzheimer disease has been well associated with mitochondrial dysfunctions. Numerous studies have reported changes in the activity of oxidative phosphorylation (OXPHOS) complexes and mitochondrial dynamics. Recently, dynamin-related protein 1 (Drp-1) has been conceived as a potential therapeutic target as well. We have examined the effect of prolonged treatment of Trans-ferulic acid on streptozocin-induced sporadic dementia of Alzheimer's type. We have found the Ferulic Acid (FA,100 mg/kg) can rescue memory and learning problems and also show significant antioxidant effect while preserving morphology of pyramidal cell layer in hippocampi. Furthermore, FA treatment has shown mitigation in intracerebral-ventricular streptozocin (ICV-STZ) induced bioenergetics loss and dynamic changes by regulating peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) protein levels in nucleus and hence, mitigating exacerbation of Drp-1 dependent mitochondrial fission and apoptosis by alleviating loss of mitochondrial membrane potential (ΔΨm), downregulating cytochrome-c release into the cytosol by limiting mitochondrial permeability transition pore (mPTP) opening concomitant increase in caspase3 activation, BAX expression and DNA fragmentation along with downregulating glial fibrillary acidic protein (GFAP) expression. FA also restored protein expression of mitofusin2 (Mfn2) a core component of mitochondrial fusion, necessary for mitophagy. We conclude that FA acid may have the propensity to mitigate mitochondrial dysfunction in Alzheimer's disease on prolonging dietary supplementation.


Subject(s)
Alzheimer Disease/drug therapy , Coumaric Acids/administration & dosage , Energy Metabolism/drug effects , Hippocampus/drug effects , Mitochondria/drug effects , Mitochondrial Dynamics/drug effects , Neurons/drug effects , Neuroprotective Agents/administration & dosage , Alzheimer Disease/chemically induced , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/metabolism , Behavior, Animal/drug effects , Disease Models, Animal , Drug Administration Schedule , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/physiopathology , Male , Membrane Potential, Mitochondrial/drug effects , Memory/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Neurons/metabolism , Neurons/pathology , Oxidative Stress/drug effects , Rats, Wistar , Spatial Learning/drug effects , Streptozocin , Time Factors
3.
Drug Dev Res ; 79(5): 218-224, 2018 08.
Article in English | MEDLINE | ID: mdl-30188583

ABSTRACT

Preclinical Research & Development Parkinson's disease (PD) is the second most common neurodegenerative disorder that affects approximately 10 million people worldwide. The risk of developing PD and similar neurodegenerative disorders increases with age and an estimated 4% people are diagnosed with the disease before reaching the age of 50. Oxidative stress, cytotoxicity, and mitochondrial dysfunction are common features exhibited in the development of PD. The 6-hyroxydopamine (6-OHDA) model of PD is one of the most well characterized and studied models of the disease. 6-OHDA, a neurotoxin, can induce most characteristic features of the disease, including mitochondrial dysfunction in-vivo and in-vitro. SH-SY5Y is a neuroblastoma cell line of human origin that has been used for dose response studies on PD in the past. Based on previous data, we have used SH-SY5Y cells as an in-vitro model of PD to analyse the phytomedicinal potential of perillyl alcohol (PA), a monoterpenoid obtained from essential oils of various plants such as sage, peppermint and lavender. We have found that pretreatment with PA (10 µM and 20 µM) mitigated 6-OHDA (150 µM) induced cytotoxicity in a dose-dependent manner. We observed marked restoration of cell viability and mitochondrial membrane potential (MMP) as well as reduced reactive oxygen species generation, Cytochrome c immunofluorescence and DNA fragmentation after treatment with PA. On the basis of on our data, we have come to the conclusion that PA demonstrates sufficient neuroprotective activity to provide new avenues in therapy of PD and its apparent target being restoration of MMP can lead to better understanding of the disease.


Subject(s)
Monoterpenes/pharmacology , Neuroprotective Agents/pharmacology , Parkinson Disease/drug therapy , Phytochemicals/pharmacology , Cell Line , Cell Survival/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Humans , Membrane Potential, Mitochondrial/drug effects , Oxidopamine/pharmacology , Reactive Oxygen Species/metabolism
4.
Article in English | MEDLINE | ID: mdl-26191657

ABSTRACT

Heavy metals can significantly bioaccumulate in fish tissues. The step wise mechanism of heavy metal toxicities on fish health is still limited. The present study assessed the tissue-specific antioxidant response and oxidative stress biomarkers of commercially important fish species namely, Channa striatus and Heteropneustes fossilis inhabiting Kali River of northern India where heavy-metal load is beyond the World Health Organisation - maximum permissible limits. Heavy metals chromium (Cr), nickel (Ni), lead (Pb) and cadmium (Cd) were elevated in both fish species compared to recommended values of the Federal Environmental Protection Agency (FEPA), 1999 for edible fishes. Reduced glutathione (GSH), superoxide dismutase (SOD) and catalase (CATA) activities in all tissues (brachial, neural, renal and hepatic) were altered. Cellular lipid and protein compromisation in both fishes induced by heavy metals was determined by lipid peroxidation (LPO) and protein carbonylation (PC) assays. Micronucleus (MN) test of erythrocytes and comet assay of liver cells confirmed genotoxicity. Histopathology of the liver, kidney and brain of affected fishes was distorted significantly with its reference fishes thereby affecting the quality and quantity of these fish stocks. This raises a serious concern as these fishes are consumed by the local population which would ultimately affect human health.


Subject(s)
Antioxidants/metabolism , Catfishes , Heavy Metal Poisoning , Metals, Heavy/toxicity , Micronuclei, Chromosome-Defective/chemically induced , Oxidative Stress/drug effects , Poisoning , Water Pollutants, Chemical/toxicity , Animals , Biomarkers/metabolism , Body Burden , Brain/drug effects , Brain/metabolism , Brain/pathology , Catfishes/genetics , Catfishes/metabolism , Comet Assay , DNA Damage , Environmental Monitoring/methods , Fish Proteins/genetics , Fish Proteins/metabolism , India , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Liver/pathology , Metals, Heavy/metabolism , Micronucleus Tests , Poisoning/genetics , Poisoning/metabolism , Poisoning/pathology , Protein Carbonylation/drug effects , Risk Assessment , Rivers , Water Pollutants, Chemical/metabolism
5.
Arch Environ Contam Toxicol ; 67(2): 203-13, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24756201

ABSTRACT

The aim of the study was to evaluate the effect of heavy-metal contamination on two fish species (Channa striatus and Heteropneustes fossilis) inhabiting a small freshwater body of northern India. After being captured, each specimen was weighed, measured, and analyzed for heavy metals (chromium [Cr], nickel [Ni], and lead [Pb]). Accumulation of heavy metals was found to be significantly greater (p < 0.05) in different tissues (gill, liver, kidney, and muscle) of fishes captured from the reservoir than from the reference site. Levels of heavy-metal contamination in Shah jamal water was Cr (1.51 mg/l) > Ni (1.22 mg/l) > Pb (0.38 mg/l), which is significantly greater than World Health Organization standards. Bioaccumulation factor was calculated, and it was observed that Pb was most detrimental heavy metal. Condition factor was also influenced. Micronucleus test of fish erythrocytes and comet assay of liver cells confirmed genotoxicity induced by heavy-metal contamination in fishes. Heavy metals (Cr, Ni, and Pb) were increased in both fish species as determined using recommended values of Federal Environmental Protection Agency for edible fishes. This raises a serious concern because these fishes are consumed by the local populations and hence would ultimately affect human health.


Subject(s)
Environmental Monitoring , Fishes/metabolism , Metals, Heavy/metabolism , Water Pollutants, Chemical/metabolism , Animals , India , Metals, Heavy/analysis , Water Pollutants, Chemical/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...